Futura Medical (GB:FUM) has released an update.
Futura Medical plc, a leader in innovative sexual health products, has announced its total issued share capital as 303,703,568 Ordinary Shares, reflecting its full voting rights. The company, known for its pioneering product Eroxon, is capitalizing on its partnerships in major markets like the US and Europe to address the pressing needs in the erectile dysfunction market.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
